BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.77
Delayed Data
As of Jun 18
 +0.04 / +0.70%
Today’s Change
3.95
Today|||52-Week Range
6.67
+17.52%
Year-to-Date

Today’s Trading

Previous close5.73
Today’s open5.71
Day’s range5.67 - 5.87
Volume595,080
Average volume (3 months)881,027
Market cap$593.3M
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)-4.00%
Earnings growth (this year)-19.44%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-4.43%
P/E ratioNM
Price/Sales16.46
Price/Book7.06

Competitors

 Today’s
change
Today’s
% change
CYADCelyad SA-0.99-3.60%
NSTGNanoString Technolog...+0.04+0.29%
MRSNMersana Therapeutics...-0.51-2.57%
SELBSelecta Biosciences ...-0.08-0.63%
Data as of 4:00pm ET, 06/18/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$25.2M
Annual profit (last year)-$65.8M
Net profit margin-261.18%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts